EA200700166A1 - 4-замещённые производные хинолина, способ получения и промежуточные вещества для их приготовления и содержащие их фармацевтические композиции - Google Patents
4-замещённые производные хинолина, способ получения и промежуточные вещества для их приготовления и содержащие их фармацевтические композицииInfo
- Publication number
- EA200700166A1 EA200700166A1 EA200700166A EA200700166A EA200700166A1 EA 200700166 A1 EA200700166 A1 EA 200700166A1 EA 200700166 A EA200700166 A EA 200700166A EA 200700166 A EA200700166 A EA 200700166A EA 200700166 A1 EA200700166 A1 EA 200700166A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- preparation
- pharmaceutical compositions
- quinoline
- obtaining
- substituted derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Настоящее изобретение относится к 4-замещенным производным хинолина общей формулы Iкоторые действуют в качестве антимикробных (антибактериальных) средств. Данное изобретение также относится к способу и промежуточным соединениям для их получения и к содержащим их фармацевтическим композициям.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0407124A FR2872164B1 (fr) | 2004-06-29 | 2004-06-29 | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
PCT/FR2005/001598 WO2006010831A1 (fr) | 2004-06-29 | 2005-06-24 | Derives de quinoleines-4-substituees, leur procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200700166A1 true EA200700166A1 (ru) | 2007-06-29 |
Family
ID=34954685
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200700166A EA200700166A1 (ru) | 2004-06-29 | 2005-06-24 | 4-замещённые производные хинолина, способ получения и промежуточные вещества для их приготовления и содержащие их фармацевтические композиции |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080032985A1 (ru) |
EP (1) | EP1763527A1 (ru) |
JP (1) | JP2008504351A (ru) |
KR (1) | KR20070029763A (ru) |
CN (1) | CN101023076A (ru) |
AU (1) | AU2005266218A1 (ru) |
CA (1) | CA2571668A1 (ru) |
EA (1) | EA200700166A1 (ru) |
FR (1) | FR2872164B1 (ru) |
IL (1) | IL179709A0 (ru) |
TW (1) | TW200609221A (ru) |
WO (1) | WO2006010831A1 (ru) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7691850B2 (en) | 2004-06-15 | 2010-04-06 | Glaxo Group Limited | Antibacterial agents |
MY150958A (en) | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
ATE481406T1 (de) | 2006-04-06 | 2010-10-15 | Glaxo Group Ltd | Pyrrolochinoxalinonderivate als antibakterielle mittel |
GB0613208D0 (en) | 2006-07-03 | 2006-08-09 | Glaxo Group Ltd | Compounds |
EP1992628A1 (en) | 2007-05-18 | 2008-11-19 | Glaxo Group Limited | Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones |
CL2008001003A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
CL2008001002A1 (es) * | 2007-04-11 | 2008-10-17 | Actelion Pharmaceuticals Ltd | Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana. |
AU2008240764C1 (en) * | 2007-04-20 | 2011-10-20 | Glaxo Group Limited | Tricyclic nitrogen containing compounds as antibacterial agents |
EP2080761A1 (en) | 2008-01-18 | 2009-07-22 | Glaxo Group Limited | Compounds |
US8012961B2 (en) | 2008-04-15 | 2011-09-06 | Actelion Pharmaceutical Ltd. | Tricyclic antibiotics |
JP2012505866A (ja) | 2008-10-17 | 2012-03-08 | グラクソ グループ リミテッド | 抗菌剤として使用される三環式窒素化合物 |
JP5653935B2 (ja) | 2009-01-15 | 2015-01-14 | グラクソ グループ リミテッドGlaxo Group Limited | 抗菌薬として有用なナフチリジン―2(1h)−オン化合物 |
ES2759303T3 (es) | 2014-08-22 | 2020-05-08 | Glaxosmithkline Ip Dev Ltd | Compuestos tricíclicos que contienen nitrógeno para tratar infección por Neisseria gonorrhoeae |
TW201722965A (zh) | 2015-08-16 | 2017-07-01 | 葛蘭素史密斯克藍智慧財產發展有限公司 | 用於抗菌應用之化合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2053340C (en) * | 1990-10-18 | 2002-04-02 | Timothy P. Burkholder | Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
JP2002505689A (ja) * | 1997-06-19 | 2002-02-19 | セプレイコー インコーポレイテッド | キノリン−インドール抗菌剤、それらに関する用途及び組成物 |
WO2000043383A1 (en) * | 1999-01-20 | 2000-07-27 | Smithkline Beecham P.L.C. | Piperidinylquinolines as protein tyrosine kinase inhibitors |
CZ2003243A3 (cs) * | 2000-07-26 | 2003-09-17 | Smithkline Beecham P. L. C. | Aminopiperidinové chinoliny a jejich azaisosterické analogy s antibakteriální aktivitou |
FR2858619B1 (fr) * | 2003-08-08 | 2006-12-22 | Aventis Pharma Sa | Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent |
-
2004
- 2004-06-29 FR FR0407124A patent/FR2872164B1/fr not_active Expired - Fee Related
-
2005
- 2005-06-16 TW TW094120002A patent/TW200609221A/zh unknown
- 2005-06-24 EA EA200700166A patent/EA200700166A1/ru unknown
- 2005-06-24 EP EP05784030A patent/EP1763527A1/fr not_active Withdrawn
- 2005-06-24 CA CA002571668A patent/CA2571668A1/en not_active Abandoned
- 2005-06-24 AU AU2005266218A patent/AU2005266218A1/en not_active Abandoned
- 2005-06-24 JP JP2007518637A patent/JP2008504351A/ja active Pending
- 2005-06-24 US US11/571,407 patent/US20080032985A1/en not_active Abandoned
- 2005-06-24 CN CNA2005800219094A patent/CN101023076A/zh active Pending
- 2005-06-24 WO PCT/FR2005/001598 patent/WO2006010831A1/fr active Application Filing
- 2005-06-24 KR KR1020067027838A patent/KR20070029763A/ko not_active Application Discontinuation
-
2006
- 2006-11-29 IL IL179709A patent/IL179709A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1763527A1 (fr) | 2007-03-21 |
FR2872164B1 (fr) | 2006-11-17 |
AU2005266218A1 (en) | 2006-02-02 |
WO2006010831A1 (fr) | 2006-02-02 |
IL179709A0 (en) | 2007-05-15 |
US20080032985A1 (en) | 2008-02-07 |
KR20070029763A (ko) | 2007-03-14 |
CN101023076A (zh) | 2007-08-22 |
JP2008504351A (ja) | 2008-02-14 |
FR2872164A1 (fr) | 2005-12-30 |
AU2005266218A2 (en) | 2006-02-02 |
CA2571668A1 (en) | 2006-02-02 |
TW200609221A (en) | 2006-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200700166A1 (ru) | 4-замещённые производные хинолина, способ получения и промежуточные вещества для их приготовления и содержащие их фармацевтические композиции | |
SE0301373D0 (sv) | Novel compounds | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
ATE362932T1 (de) | Azaindolverbindungen als kinaseinhibitoren | |
CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
EA200800540A1 (ru) | Карбоксамидные производные в качестве антагонистов мускариновых рецепторов | |
MX2010009752A (es) | Compuestos de oxadiazoantraceno para el tratamiento de diabetes. | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
UA107188C2 (uk) | Карбоксамідні похідні хіназолінів або хінолінів та фармацевтична композиція на їх основі | |
ATE517882T1 (de) | Chinolinderivate | |
SE0101675D0 (sv) | Novel composition | |
HRP20070076A2 (en) | Pyrimidine derivatives | |
EA200700188A1 (ru) | Производные замещенного 2-алкилхиназолинона как ингибиторы parp | |
EA200700099A1 (ru) | Производные пиридина | |
EA200700185A1 (ru) | Производные хиназолиндиона в качестве ингибиторов parp | |
HK1110588A1 (en) | Novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
EA201101334A1 (ru) | Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их | |
NO20064344L (no) | Caspaseinhibitorer og anvendelser derav | |
EA200702375A1 (ru) | Производные мочевины, способы их получения и применения | |
EA201190293A1 (ru) | Пролекарства триптолида | |
NO20073170L (no) | Kaspaseinhibitorer og anvendelse derav | |
EA200970124A1 (ru) | Производные 2-арилиндола в качестве ингибиторов npges-1 | |
EA200600605A1 (ru) | Перегруппированные пентанолы, способ их получения и их применение в качестве противовоспалительных средств |